News | June 30, 2024
ONGC to enhance healthcare facilities at Baltal and Chandanwari in J&K
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Subscribe To Our Newsletter & Stay Updated
